invIOs to present at upcoming conferences
03 févr. 2022 02h00 HE
|
invIOs GmbH
VIENNA, Austria, Feb. 03, 2022 (GLOBE NEWSWIRE) -- invIOs GmbH, a privately held biotechnology company developing novel therapies for cancer, today announced the participation at three upcoming...